GB9221883D0 - Novel formulation - Google Patents

Novel formulation

Info

Publication number
GB9221883D0
GB9221883D0 GB929221883A GB9221883A GB9221883D0 GB 9221883 D0 GB9221883 D0 GB 9221883D0 GB 929221883 A GB929221883 A GB 929221883A GB 9221883 A GB9221883 A GB 9221883A GB 9221883 D0 GB9221883 D0 GB 9221883D0
Authority
GB
United Kingdom
Prior art keywords
novel formulation
formulation
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929221883A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to GB929221883A priority Critical patent/GB9221883D0/en
Publication of GB9221883D0 publication Critical patent/GB9221883D0/en
Priority to IL107313A priority patent/IL107313A0/en
Priority to ZA937714A priority patent/ZA937714B/en
Priority to HU9501104A priority patent/HUT75701A/en
Priority to SI9300545A priority patent/SI9300545A/en
Priority to PCT/GB1993/002141 priority patent/WO1994008596A1/en
Priority to KR1019950701458A priority patent/KR950703345A/en
Priority to CA002147889A priority patent/CA2147889A1/en
Priority to NZ256890A priority patent/NZ256890A/en
Priority to EP93923008A priority patent/EP0671919A1/en
Priority to SK447-95A priority patent/SK44795A3/en
Priority to CZ95633A priority patent/CZ63395A3/en
Priority to MX9306467A priority patent/MX9306467A/en
Priority to AU52842/93A priority patent/AU674895B2/en
Priority to PL93308459A priority patent/PL308459A1/en
Priority to JP6509782A priority patent/JPH08502284A/en
Priority to BR9307268A priority patent/BR9307268A/en
Priority to TW082108706A priority patent/TW276183B/zh
Priority to NO951462A priority patent/NO951462L/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/77Polymers containing oxygen of oxiranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Packages (AREA)
GB929221883A 1992-10-19 1992-10-19 Novel formulation Pending GB9221883D0 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GB929221883A GB9221883D0 (en) 1992-10-19 1992-10-19 Novel formulation
TW082108706A TW276183B (en) 1992-10-19 1993-10-18
NZ256890A NZ256890A (en) 1992-10-19 1993-10-18 Sealed pharmaceutically acceptable container containing an ethyleneoxy propyleneoxy ethyleneoxy block copolymer as a sterile aqueous injectable solution having no antioxidants
SK447-95A SK44795A3 (en) 1992-10-19 1993-10-18 Composition based on polyoxyethylene-polyoxypropylene block copolymers and container containing it
HU9501104A HUT75701A (en) 1992-10-19 1993-10-18 Composition based on polyoxyethylene-polyoxypropylene block copolymers and container containing it
SI9300545A SI9300545A (en) 1992-10-19 1993-10-18 Stable pharmaceutical formulation of a polyoxypropylene/polyoxyethylene block copolymer
PCT/GB1993/002141 WO1994008596A1 (en) 1992-10-19 1993-10-18 Composition based on polyoxyethylene-polyoxypropylene block copolymers and container containing it
KR1019950701458A KR950703345A (en) 1992-10-19 1993-10-18 COMPOSITION BASED ON POLYOXYETHYLENE-POLYOXYPROPYLENE BLOCK COPOLYMERS AND CONTAINER CONTANING IT
CA002147889A CA2147889A1 (en) 1992-10-19 1993-10-18 Composition based on polyoxyethylene-polyoxypropylene block copolymers and container containing it
IL107313A IL107313A0 (en) 1992-10-19 1993-10-18 Pharmaceutically acceptable container containing an injectable solution of a polyoxypropylene/polyoxyethylene
EP93923008A EP0671919A1 (en) 1992-10-19 1993-10-18 Composition based on polyoxyethylene-polyoxypropylene block copolymers and container containing it
ZA937714A ZA937714B (en) 1992-10-19 1993-10-18 Novel formulation
CZ95633A CZ63395A3 (en) 1992-10-19 1993-10-18 Composition based on polyoxyethylene-polyoxypropylene block co-polymers and a tank containing thereof
MX9306467A MX9306467A (en) 1992-10-19 1993-10-18 NOVEL FORMULATION.
AU52842/93A AU674895B2 (en) 1992-10-19 1993-10-18 Composition based on polyoxyethylene-polyoxypropylene block copolymers and container containing it
PL93308459A PL308459A1 (en) 1992-10-19 1993-10-18 Polyoxyethylene/polyoxypropylene block copolymer based composition and container holding such composition
JP6509782A JPH08502284A (en) 1992-10-19 1993-10-18 Composition based on polyoxyethylene / polyoxypropylene block copolymer and container containing the same
BR9307268A BR9307268A (en) 1992-10-19 1993-10-18 Pharmaceutically acceptable sealed container
NO951462A NO951462L (en) 1992-10-19 1995-04-18 Preparation based on polyoxyethylene-polyoxypropylene block copolymers and container containing the preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929221883A GB9221883D0 (en) 1992-10-19 1992-10-19 Novel formulation

Publications (1)

Publication Number Publication Date
GB9221883D0 true GB9221883D0 (en) 1992-12-02

Family

ID=10723654

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929221883A Pending GB9221883D0 (en) 1992-10-19 1992-10-19 Novel formulation

Country Status (19)

Country Link
EP (1) EP0671919A1 (en)
JP (1) JPH08502284A (en)
KR (1) KR950703345A (en)
AU (1) AU674895B2 (en)
BR (1) BR9307268A (en)
CA (1) CA2147889A1 (en)
CZ (1) CZ63395A3 (en)
GB (1) GB9221883D0 (en)
HU (1) HUT75701A (en)
IL (1) IL107313A0 (en)
MX (1) MX9306467A (en)
NO (1) NO951462L (en)
NZ (1) NZ256890A (en)
PL (1) PL308459A1 (en)
SI (1) SI9300545A (en)
SK (1) SK44795A3 (en)
TW (1) TW276183B (en)
WO (1) WO1994008596A1 (en)
ZA (1) ZA937714B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008287419A1 (en) * 2007-08-10 2009-02-19 Synthrx, Inc. Polymer therapy for the treatment of chronic microvascular diseases
EP3057598A1 (en) 2013-10-16 2016-08-24 Mast Therapeutics, Inc. Diuretic induced alterations of plasma volume
WO2016007542A1 (en) 2014-07-07 2016-01-14 Mast Therapeutics, Inc. Poloxamer therapy for heart failure
US9757411B2 (en) 2014-07-07 2017-09-12 Aires Pharmaceuticals, Inc. Poloxamer therapy for heart failure
WO2016007537A1 (en) 2014-07-07 2016-01-14 Mast Therapeutics, Inc. A poloxamer composition free of long circulating material and methods for production and uses thereof
CN109432511A (en) * 2018-12-29 2019-03-08 常州乐奥医疗科技股份有限公司 A kind of temperature-sensitive hydrogel and its preparation method and application

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641240A (en) * 1968-09-27 1972-02-08 Wyandotte Chemicals Corp Method for the treatment of an embolus or thrombus
DE3234084A1 (en) * 1982-09-14 1984-03-15 B. Braun Melsungen Ag, 3508 Melsungen PHARMACEUTICAL PREPARATIONS FOR TREATING UNWANTED GROWTHS AND THEIR USE
US4879109A (en) * 1986-05-15 1989-11-07 Emory University Method for treating burns
US4938961A (en) * 1989-04-28 1990-07-03 Geoffrey Collins Organ preservation solution containing pokyethylene gycol and method of performing cardioplegia

Also Published As

Publication number Publication date
AU5284293A (en) 1994-05-09
HUT75701A (en) 1997-05-28
JPH08502284A (en) 1996-03-12
WO1994008596A1 (en) 1994-04-28
SK44795A3 (en) 1996-05-08
TW276183B (en) 1996-05-21
NO951462D0 (en) 1995-04-18
NZ256890A (en) 1995-10-26
IL107313A0 (en) 1994-01-25
AU674895B2 (en) 1997-01-16
BR9307268A (en) 1999-05-11
NO951462L (en) 1995-06-13
HU9501104D0 (en) 1995-06-28
KR950703345A (en) 1995-09-20
EP0671919A1 (en) 1995-09-20
MX9306467A (en) 1994-05-31
SI9300545A (en) 1994-06-30
CZ63395A3 (en) 1995-07-12
CA2147889A1 (en) 1994-04-28
PL308459A1 (en) 1995-07-24
ZA937714B (en) 1995-04-18

Similar Documents

Publication Publication Date Title
GB9325644D0 (en) Novel formulation
GB2268499B (en) Chipping-resistant composition
GB9103824D0 (en) Formulation
GB9214390D0 (en) Formulations
HUT68891A (en) Novel amidoalkyl- and imidoalkyl-piperazines
GB9221883D0 (en) Novel formulation
GB9207400D0 (en) Novel use
HRP930179A2 (en) Novel antioksidants
GB2272222B (en) Command-curable composition
LTIP348A (en) Novel sulfonylcarbamides
GB9216361D0 (en) Novel formulation
GB9212757D0 (en) Novel formulation
GB9212711D0 (en) Novel formulation
GB9108128D0 (en) Novel formulation
GB9201915D0 (en) Formulation
GB9202110D0 (en) Formulation
GB9217322D0 (en) Formulation
GB9225583D0 (en) Formulation
ZA928061B (en) Lipomimetic formulation
GB9205183D0 (en) Formulation
ZA93795B (en) Novel triazolopyrimidinesulfonamides
GB9316326D0 (en) Novel formulation
GB9312355D0 (en) Novel formulation
GB9312354D0 (en) Novel formulation
GB9126687D0 (en) Novel formulation